Johnson & Johnson’s Post

“Global life sciences R&D efforts primarily focus on conditions with a high contribution of years of life lost to the overall disease-adjusted life years. This has often disadvantaged women and girls because they have a higher probability of being affected by conditions that affect quality of life (years lived with a disability) rather than length of life. Even in the digital healthcare space, FemTech companies received only 3% of the total digital health funding.” Learn more in this blog by Shyam Bishen, Ph.D., MS, MBA from the World Economic Forum and Lucy Perez, Senior Partner & CoLeader of the McKinsey Health Institute: https://lnkd.in/eznKH8WR #CloseTheWomensHealthGap #womenshealth #globalhealth #wef24

An excellent professional, and person

By embracing the "Enlightened Horizons" strategy, Research envisions a future where clinical research not only advances scientific knowledge but also positively impacts the lives of individuals and communities. Through patient-centric approaches, innovative trial design, personalized care advancements, community collaboration, and elevated ethical standards, Research strives to drive positive change in the field of clinical research. This visionary strategy enables the organization to remain at the forefront of industry advancements, adapt to evolving trends, and ultimately deliver better outcomes for patients. By leveraging cutting-edge technologies, forging partnerships, empowering patients, and upholding ethical principles, Research is poised to shape the future of clinical research and make a lasting impact on the lives of countless individuals. #EnlightenedHorizonsVision #PatientCentricResearch #InnovateClinicalTrials #PersonalizedCareImpact #CommunityCollabResearch #EthicalStandardsInResearch

𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘀𝗶𝗻𝗴 𝗛𝗲𝗮𝗹𝘁𝗵 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 Ever wondered why some groups remain overlooked in clinical trials? It’s a persistent issue, but change is on the horizon! Legislation like the DEPICT Act in the US and new UK guidelines are ushering in a new era. Global collaborations and tech advancements are tearing down old barriers. Advocacy groups rising in influence, promising a future where health research is diverse and inclusive. https://lnkd.in/ekDSkp26 #DemandDiversity #DiversityinClinicalTrials What role can you play in this transformation? Share your thoughts

In the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center)’s Achieving Diversity, Inclusion, and Equity in Clinical Research Guidance Document, we note throughout the document the importance of working to facilitate trial participation for people living in rural areas (e.g., see Figure 27 with the Case Example: Apoyo con Cariño). But how do we define rural, urban, and peri/suburban? The Rural Health Research Gateway gave a recent webinar on the topic; slides are now available. How Does the Definition of “Rural” Impact Research? (ruralhealthresearch.org): https://lnkd.in/gpik_ExP

The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center)'s "Achieving Diversity, Inclusion, and Equity in Clinical Research" toolkit is a comprehensive roadmap for clinical research organizations, providing actionable strategies to enhance diversity and inclusion in clinical trials. A key feature of this toolkit is the detailed organizational checklist, which guides institutions through practical steps to assess and improve their diversity and inclusion practices in research settings, ensuring that studies are more representative and inclusive of diverse populations. #ClinicalResearch #DiversityInResearch #HealthEquity #InclusiveTrials https://bit.ly/48sIPxH

The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) "Achieving Diversity, Inclusion, and Equity in Clinical Research" toolkit is a comprehensive roadmap for clinical research organizations, providing actionable strategies to enhance diversity and inclusion in clinical trials. A key feature of this toolkit is the detailed organizational checklist, which guides institutions through practical steps to assess and improve their diversity and inclusion practices in research settings, ensuring that studies are more representative and inclusive of diverse populations. #ClinicalResearch #DiversityInResearch #HealthEquity #InclusiveTrials https://bit.ly/48sIPxH

This week, our founder & CEO Kate Ryder joined Dame Vivian Hunt, Chief Innovation Officer of UnitedHealth Group, for a fireside chat on “The New Era of Health Equity” at London Tech Week. Some key takeaways: 🌟 Look to the data: patterns can often help identify gaps in care that can be bridged, which is crucial for improving health outcomes. 🌟 Women are the “chief medical officer of their homes”: women make 80% of healthcare decisions, underscoring the importance of tailored, comprehensive care models. By centering women, we are better equipped to tackle health equity issues. 🌟Technology enables access: When technology intersects with culturally competent care, we can offer accessible, personalized support to women—regardless of geography.

💡 The Power of Perspective: Centering Equity in Problem Framing Practices It’s frustrating to see the same old story play out: minority groups are underrepresented in clinical trials, and the proposed solution is usually some variation of “let’s translate our materials and do more outreach.” Seriously in 2024? This problem isn’t just about language barriers or lack of awareness. It runs much deeper, touching on historical injustices, systemic inequities, and a fundamental lack of trust. Whenever the topic of minority underrepresentation in clinical trials comes up, the conversation often zeroes in on recruitment difficulties. The solutions offered typically involve translating materials into different languages or increasing community outreach. These efforts barely scratch the surface of the real problem. The question we need to be asking is: 👉🏽 Why do researchers and institutions struggle to gain the trust and participation of minority groups in clinical trials? 👉🏽 What are the historical, social, and systemic barriers that discourage or prevent their participation? 👉🏽 How have past and present inequalities shaped their trust (or lack thereof) in medical research? Trust is critical here. Researchers and institutions must actively work to build and maintain trust with minority communities and work on themselves to be trustworthy. This goes beyond just outreach, it requires a commitment to ethical practices, transparency, and accountability. Researchers and institutions have a crucial role in reframing this issue. It starts with recognising the historical and systemic factors at play and actively working to address them. This includes building genuine partnerships with communities, involving them in the research process from the beginning, and ensuring that research agendas reflect their needs and concerns. Demonstrating trustworthiness through consistent, ethical, and transparent practices is essential in this process. Centering equity in problem framing isn’t just about increasing minority participation in clinical trials, it’s about transforming the entire research ecosystem to be more inclusive, just, and representative. It’s about recognising and addressing the power dynamics and historical injustices that have shaped current practices. What do you think are the most critical steps researchers and institutions can take to build trust and ensure greater equity in clinical trials? #equity #trust #clinicaltrials

When women are enabled to reach their full potential, everyone benefits. But severe inequities in health outcomes — especially related to maternal and reproductive care — currently place women around the world at risk. Throughout her work at BCG, Sarah Chamberlain has discovered the urgent need to enhance both funding and innovation in women's health care. She's found that, although the tools to ensure better outcomes exist, we need collaboration from innovators, payors, and providers to make them more accessible. Learn more about how cross-sector investment can make a real change in women's health care: https://lnkd.in/e7C_ADR4